NeoGenomics Laboratories Inc is a leading provider of cancer-focused genetic testing services. The company offers a comprehensive suite of diagnostic, prognostic, and predictive testing solutions, assisting healthcare providers in improving patient care through precision medicine. Their services include a wide range of tests such as molecular testing, next-generation sequencing, cytogenetics, fluorescence in situ hybridization (FISH), and immunohistochemistry. NeoGenomics is dedicated to innovation, quality, and providing actionable insights for oncologists, pathologists, and researchers.